BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

714 related articles for article (PubMed ID: 17498851)

  • 21. Induction of Th1 and Th2 CD4+ T cell responses by oral or parenteral immunization with ISCOMS.
    Maloy KJ; Donachie AM; Mowat AM
    Eur J Immunol; 1995 Oct; 25(10):2835-41. PubMed ID: 7589080
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CpG DNA is a potent enhancer of systemic and mucosal immune responses against hepatitis B surface antigen with intranasal administration to mice.
    McCluskie MJ; Davis HL
    J Immunol; 1998 Nov; 161(9):4463-6. PubMed ID: 9794366
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CpG ODN can re-direct the Th bias of established Th2 immune responses in adult and young mice.
    Weeratna RD; Brazolot Millan CL; McCluskie MJ; Davis HL
    FEMS Immunol Med Microbiol; 2001 Dec; 32(1):65-71. PubMed ID: 11750224
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of novel lipidated analogs of picroside as vaccine adjuvants: acylated analogs of picroside-II elicit strong Th1 and Th2 response to ovalbumin in mice.
    Kumar HM; Singh PP; Qazi NA; Srinivas J; Malik F; Sidiq T; Gupta A; Khajuria A; Suri KA; Satti NK; Qazi GN
    Vaccine; 2010 Dec; 28(52):8327-37. PubMed ID: 20688035
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Platycodin D is a potent adjuvant of specific cellular and humoral immune responses against recombinant hepatitis B antigen.
    Xie Y; Sun HX; Li D
    Vaccine; 2009 Jan; 27(5):757-64. PubMed ID: 19041358
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduced hepatitis B virus surface antigen-specific Th1 helper cell frequency of chronic HBV carriers is associated with a failure to produce antigen-specific antibodies in the trimera mouse.
    Böcher WO; Galun E; Marcus H; Daudi N; Terkieltaub D; Shouval D; Löhr HF; Reisner Y
    Hepatology; 2000 Feb; 31(2):480-7. PubMed ID: 10655274
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy evaluation of two synthetic lysine lipidated tripeptides as vaccine adjuvants against HBsAg.
    Sidiq T; Khajuria A; Shafi S; Ismail T; Sampath Kumar H; Kannappa Srinivas V; Krishna E; Kamal Johri R
    Eur J Pharmacol; 2013 Apr; 705(1-3):68-78. PubMed ID: 23474022
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alginate coated chitosan nanoparticles are an effective subcutaneous adjuvant for hepatitis B surface antigen.
    Borges O; Silva M; de Sousa A; Borchard G; Junginger HE; Cordeiro-da-Silva A
    Int Immunopharmacol; 2008 Dec; 8(13-14):1773-80. PubMed ID: 18801462
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A mixed Th1/Th2 response elicited by a liposomal formulation of Leishmania vaccine instructs Th1 responses and resistance to Leishmania donovani in susceptible BALB/c mice.
    Mazumdar T; Anam K; Ali N
    Vaccine; 2004 Mar; 22(9-10):1162-71. PubMed ID: 15003644
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunomodulatory activity of novel adjuvant formulations based on Montanide ISA oil-based adjuvants and peptidoglycan monomer.
    Habjanec L; Halassy B; Tomasić J
    Int Immunopharmacol; 2008 May; 8(5):717-24. PubMed ID: 18387514
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bursin as an adjuvant is a potent enhancer of immune response in mice immunized with the JEV subunit vaccine.
    Wang C; Wen WY; Su CX; Ge FF; Dang ZG; Duan XG; Cao RB; Zhou B; Chen PY
    Vet Immunol Immunopathol; 2008 Apr; 122(3-4):265-74. PubMed ID: 18191231
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [C3d molecular adjuvant increases the immunity of human chorionic gonadotropin beta DNA contraceptive vaccination and changes its immune response from Th1 to Th2].
    Zhao XR; Li DJ; Yuan MM; Cai LR; Sun XX
    Zhonghua Yi Xue Za Zhi; 2003 Nov; 83(21):1906-9. PubMed ID: 14642077
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Platycodin D2 is a potential less hemolytic saponin adjuvant eliciting Th1 and Th2 immune responses.
    Xie Y; Deng W; Sun H; Li D
    Int Immunopharmacol; 2008 Aug; 8(8):1143-50. PubMed ID: 18550019
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction of systemic Th1 and Th2 immune responses by oral administration of soluble antigen and diesel exhaust particles.
    Yoshino S; Sagai M
    Cell Immunol; 1999 Feb; 192(1):72-8. PubMed ID: 10066349
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An α-GalCer analogue with branched acyl chain enhances protective immune responses in a nasal influenza vaccine.
    Lee YS; Lee KA; Lee JY; Kang MH; Song YC; Baek DJ; Kim S; Kang CY
    Vaccine; 2011 Jan; 29(3):417-25. PubMed ID: 21087689
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immune response induced by a different combined immunization of HBsAg vaccine.
    Wu T; Chen M; Ou SH; Cheng T; Zhang J; Xia NS
    Intervirology; 2007; 50(5):336-40. PubMed ID: 17700028
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HCV core protein immunization with Montanide/CpG elicits strong Th1/Th2 and long-lived CTL responses.
    Roohvand F; Aghasadeghi MR; Sadat SM; Budkowska A; Khabiri AR
    Biochem Biophys Res Commun; 2007 Mar; 354(3):641-9. PubMed ID: 17250802
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of methotrexate on Th1 and Th2 immune responses in mice.
    Yamaki K; Uchida H; Harada Y; Li X; Yanagisawa R; Takano H; Hayashi H; Taneda S; Mori Y; Yoshino S
    J Pharm Pharmacol; 2003 Dec; 55(12):1661-6. PubMed ID: 14738593
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A standardized root extract of Withania somnifera and its major constituent withanolide-A elicit humoral and cell-mediated immune responses by up regulation of Th1-dominant polarization in BALB/c mice.
    Malik F; Singh J; Khajuria A; Suri KA; Satti NK; Singh S; Kaul MK; Kumar A; Bhatia A; Qazi GN
    Life Sci; 2007 Mar; 80(16):1525-38. PubMed ID: 17336338
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of intranasal IL-12 to target predominantly Th1 responses to nasal and Th2 responses to oral vaccines given with cholera toxin.
    Marinaro M; Boyaka PN; Jackson RJ; Finkelman FD; Kiyono H; Jirillo E; McGhee JR
    J Immunol; 1999 Jan; 162(1):114-21. PubMed ID: 9886376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.